COGNITANT GROUP SET FOR 2020 EXPANSION AFTER SUCCESSFUL DEBUT YEAR
Oxford-based healthtech company Cognitant Group is poised for further growth and expansion in 2020 following a successful first year of operations.
Cognitant Group provides immersive health information to patients via their smartphones, tablets or VR headsets in a bid to improve health literacy and tackle misinformation by making healthcare information more accessible.
The company, founded by medical and technology professionals, has signed deals with numerous global pharmaceutical companies and has expanded to cover areas including women’s health, rheumatoid arthritis, asthma, and cardiovascular disease, whilst simultaneously developing partnerships with Oxford University Hospital, Cambridge University Hospital, The Royal Brompton, Wessex Academic Health Science Network (AHSN), Manchester Health Clinical Commissioning, and many other institutions across the UK.
Cognitant Group also won the Technology Excellence Award at the 2019 Oxford Business Awards (OXBA), for Healthinote: a platform that enables doctors and healthcare professionals to prescribe information to patients simply and quickly, either face to face or via virtual consultation.
2019 also saw significant development in Cognitant Group’s immersive content across all areas of health, with plans to expand in 2020 with projects planned for Germany, Italy, Spain, France and South America.
Cognitant is set to develop key clinical therapy areas in 2020, including heart failure, cancer, kidney disease, intensive care, sickle cell disease, diabetes and COPD.
Cognitant Group’s founder and CEO Dr Tim Ringrose said, “2019 has been a fantastic year for Cognitant Group and we have enormous support from patients, healthcare professionals and industry. As we look forward to 2020, we already have projects planned across Europe and even into South America as we continue on our mission to improve revolutionise healthcare information.”
Looking to empower people with health information for better patient outcomes?
Co-creating content with patients: a guide for the life sciences industry
Download the full whitepaper here Executive summary: WHAT IS CO-CREATION? In recent times, the life sciences industry has been trying to find better ways to...
Information: the most powerful prescription a clinician can make
At this year's HETT 21 event, CEO Dr Tim Ringrose gave a talk on why he thinks that information is the most powerful prescription a...
Panel discussion, 22nd September: Improving patient outcomes - is digital the solution?
How can we tackle the need to improve patient outcomes? Does digital have the answer? A panel discussion addressing these questions will take place at...